Antiplatelets

Contributing journals to this collection:
Hypertension, Circulation: Heart Failure, Stroke, Circulation Research, Circulation: Arrhythmia and Electrophysiology, Circulation: Cardiovascular Genetics, Arteriosclerosis, Thrombosis, and Vascular Biology, Circulation: Cardiovascular Outcomes and Quality, Circulation, Circulation: Cardiovascular Interventions, and Circulation: Cardiovascular Imaging

Citations 1-10 of 384 total displayed.

Most recent content

Emerging Therapies
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation: Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Raymond Chee-Seong Seet and Christopher P.L. Chen
Stroke 2009;40:3883-3885; published online before print as doi:10.1161/STROKEAHA.109.568576 [Full text]  

Past content

Articles
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation. Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Raymond Chee-Seong Seet and Christopher P.L. Chen
Stroke published October 29, 2009, doi:10.1161/STROKEAHA.109.568576 [Abstract]  

Editorials
Reducing Stroke Rates in Patients With Atrial Fibrillation: How Low Can We Go?

Michael D. Ezekowitz, Meghashyam J. Koti, and Brian Fulton
Circulation 2009;120:1169-1170; published online before print as doi:10.1161/CIRCULATIONAHA.109.893438 [Full text]  

Articles
Reducing Stroke Rates in Patients With Atrial Fibrillation. How Low Can We Go?

Michael D. Ezekowitz, Meghashyam J. Koti, and Brian Fulton
Circulation published September 14, 2009, doi:10.1161/CIRCULATIONAHA.109.893438 [Abstract]  

Research Letters
Sarpogrelate Versus Aspirin in Secondary Prevention of Cerebral Infarction: Differential Efficacy in Diabetes?: Subgroup Analysis From S-ACCESS

Yukito Shinohara, Katsuya Nishimaru for the S-ACCESS study group
Stroke 2009;40:2862-2865; published online before print as doi:10.1161/STROKEAHA.109.554246 [Abstract] [Full text]  

Articles
Sarpogrelate Versus Aspirin in Secondary Prevention of Cerebral Infarction: Differential Efficacy in Diabetes? Subgroup Analysis From S-ACCESS

Yukito Shinohara, Katsuya Nishimaru for the S-ACCESS study group
Stroke published June 11, 2009, doi:10.1161/STROKEAHA.109.554246 [Abstract]  

Clinician Update
Can We Override Clopidogrel Resistance?

Ana Pena, Jean-Philippe Collet, Jean-Sébastien Hulot, Johanne Silvain, Olivier Barthélémy, Farzin Beygui, Christian Funck-Brentano, and Gilles Montalescot
Circulation 2009;119:2854-2857, doi:10.1161/CIRCULATIONAHA.108.857722 [Full text]  

Original Contributions
Effect of Antiplatelet Therapy for Endovascular Coiling in Aneurysmal Subarachnoid Hemorrhage

Walter M. van den Bergh, Richard S.C. Kerr, Ale Algra, Gabriel J.E. Rinkel, Andrew J. Molyneux for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group
Stroke 2009;40:1969-1972; published online before print as doi:10.1161/STROKEAHA.108.528802 [Abstract] [Full text]  

Topical Reviews
Treatment of Atherosclerotic Intracranial Arterial Stenosis

Tanya N. Turan, Colin P. Derdeyn, David Fiorella, and Marc I. Chimowitz
Stroke 2009;40:2257-2261; published online before print as doi:10.1161/STROKEAHA.108.537589 [Full text]  

Controversies in Stroke
Need for a Point-of-Care Assay for Monitoring Antiplatelet and Antithrombotic Therapies

Gundu H.R. Rao
Stroke 2009;40:2271-2272; published online before print as doi:10.1161/STROKEAHA.108.537621 [Full text]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39